Osaic Holdings’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.8K Buy
298
+132
+80% +$8.6K ﹤0.01% 5964
2025
Q4
$13.3K Sell
166
-1,284
-89% -$86.3K ﹤0.01% 6150
2025
Q3
$71.2K Buy
1,450
+1,310
+936% +$81.1K ﹤0.01% 5066
2025
Q2
$10.4K Buy
140
+37
+36% +$2.45K ﹤0.01% 6125
2025
Q1
$6.54K Buy
103
+62
+151% +$4.22K ﹤0.01% 6028
2024
Q4
$3.2K Buy
+41
New +$3.29K ﹤0.01% 6413
2024
Q3
Sell
-209
Closed -$17.3K 7469
2024
Q2
$17.3K Buy
209
+47
+29% +$4.13K ﹤0.01% 5444
2024
Q1
$13.8K Sell
162
-728
-82% -$57.1K ﹤0.01% 5569
2023
Q4
$76.1K Sell
890
-73
-8% -$6.31K ﹤0.01% 4610
2023
Q3
$86.3K Sell
963
-334
-26% -$29.8K ﹤0.01% 4613
2023
Q2
$110K Buy
1,297
+52
+4% +$4.4K ﹤0.01% 4361
2023
Q1
$103K Buy
1,245
+67
+6% +$5.42K ﹤0.01% 4424
2022
Q4
$93K Buy
1,178
+48
+4% +$3.86K ﹤0.01% 4496
2022
Q3
$83K Sell
1,130
-69
-6% -$4.95K ﹤0.01% 4523
2022
Q2
$78K Buy
1,199
+129
+12% +$7.63K ﹤0.01% 4614
2022
Q1
$58K Buy
1,070
+138
+15% +$7.5K ﹤0.01% 4992
2021
Q4
$49K Sell
932
-576
-38% -$35.1K ﹤0.01% 5161
2021
Q3
$107K Buy
1,508
+98
+7% +$6.18K ﹤0.01% 4466
2021
Q2
$94K Sell
1,410
-8
-0.6% -$566 ﹤0.01% 4529
2021
Q1
$158K Sell
1,418
-465
-25% -$57.5K ﹤0.01% 3957
2020
Q4
$225K Sell
1,883
-124
-6% -$13.3K ﹤0.01% 3370
2020
Q3
$180K Buy
2,007
+35
+2% +$3.06K ﹤0.01% 3345
2020
Q2
$178K Buy
1,972
+141
+8% +$14.2K ﹤0.01% 3234
2020
Q1
$185K Buy
+1,831
New +$199K ﹤0.01% 2936

Other funds holding HAE

Osaic Holdings's HAE Position: Q1 2026 in Review

Osaic Holdings increased its Haemonetics (HAE) stake by 80% in Q1 2026, buying an estimated $8.6K and bringing the position to 298 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5964.

Osaic Holdings first reported a position in HAE in Q1 2020 and has held it in 24 quarters since. The position peaked at $225K in Q4 2020. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Osaic Holdings held 298 shares of Haemonetics worth $16.8K as of Q1 2026.
  • Osaic Holdings bought 132 Haemonetics shares in Q1 2026, an estimated $8.6K.
  • Haemonetics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5964 holding.
  • Osaic Holdings first reported a position in Haemonetics in Q1 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Haemonetics position peaked at $225K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.